Stock Events

Stock Events

Quantum Cyber N.V. 

$3.33
123
-$0.24-6.72% Friday 20:00

Statistics

Day High
3.72
Day Low
3.33
52W High
4.43
52W Low
0.3
Volume
8,640,800
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15MayExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
-4.79
-3.24
-1.69
-0.14
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,424.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.79MRevenue
-43.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QUCY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap12.59B
Guardant Health, Inc. provides liquid biopsy tests that detect cancer and cancer treatment targets, competing in the broader cancer diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap445.89M
Fulgent Genetics, Inc. provides comprehensive genetic testing solutions for various diseases, including cancer, competing in the genetic testing market.
Qiagen NV
QGEN
Mkt Cap6.8B
Qiagen N.V. offers sample and assay technologies for molecular diagnostics, including cancer, competing in the molecular diagnostics market.
Pacific Biosciences of California
PACB
Mkt Cap347.87M
Pacific Biosciences of California, Inc. offers sequencing systems that could be used in cancer research and diagnostics, indirectly competing in the genomics space.
Illumina
ILMN
Mkt Cap21.57B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, which are crucial in cancer research and diagnostics, making it a competitor in the genomics field.
TG Therapeutics
TGTX
Mkt Cap6.05B
TG Therapeutics, Inc. focuses on developing treatments for B-cell malignancies and autoimmune diseases, competing in the broader oncology and biopharmaceutical market.
Adaptive Biotechnologies
ADPT
Mkt Cap2.05B
Adaptive Biotechnologies Corp. offers clonoSEQ, a diagnostic test for detecting minimal residual disease in blood cancers, competing in the cancer diagnostics and monitoring market.

About

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Show more...
CEO
Mr. David Elliot Lazar
Employees
26
Country
Netherlands
ISIN
NL0015000LC2

Listings

MU
DE
4TO.MU
F
DE
4TO.F
BOATS
BOATS
MYNZ.BOATS
XNAS
US
QUCY

0 Comments

Share your thoughts

FAQ

What is Quantum Cyber N.V. stock price today?▼
The current price of QUCY is $3.33 USD — it has decreased by -6.72% in the past 24 hours. Watch Quantum Cyber N.V. stock price performance more closely on the chart.
What is Quantum Cyber N.V. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum Cyber N.V. stocks are traded under the ticker QUCY.
When is the next Quantum Cyber N.V. earnings date?▼
Quantum Cyber N.V. is going to release the next earnings report on September 09, 2026.
What is Quantum Cyber N.V. revenue for the last year?▼
Quantum Cyber N.V. revenue for the last year amounts to 1.79M USD.
What is Quantum Cyber N.V. net income for the last year?▼
QUCY net income for the last year is -43.3M USD.
How many employees does Quantum Cyber N.V. have?▼
As of May 24, 2026, the company has 26 employees.
In which sector is Quantum Cyber N.V. located?▼
Quantum Cyber N.V. operates in the Other sector.
When did Quantum Cyber N.V. complete a stock split?▼
Quantum Cyber N.V. has not had any recent stock splits.
Where is Quantum Cyber N.V. headquartered?▼
Quantum Cyber N.V. is headquartered in Mainz, Netherlands.